Meta-analysis of TNF-α promoter −308 A/G polymorphism and SLE susceptibility

[1]  J. Anaya,et al.  Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. , 2005, The Journal of rheumatology.

[2]  J. Harley,et al.  Genetics of human systemic lupus erythematosus: the emerging picture. , 2004, Current opinion in immunology.

[3]  Thomas A Trikalinos,et al.  'Racial' differences in genetic effects for complex diseases , 2004, Nature Genetics.

[4]  M. Azizah,et al.  Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. , 2004, Asian Pacific journal of allergy and immunology.

[5]  G. Cooper,et al.  Genetic polymorphisms in tumor necrosis factor (TNF)-α and TNF-β in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1α-889 C/T polymorphism , 2004 .

[6]  K. Van Steen,et al.  Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. , 2003, Gastroenterology.

[7]  Thomas A Trikalinos,et al.  The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. , 2003, Kidney international.

[8]  James T. Elder,et al.  Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. , 2002, American journal of human genetics.

[9]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[10]  J. Ioannidis,et al.  Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. , 2002, Arthritis and rheumatism.

[11]  Najia Shakoor,et al.  Drug-induced systemic lupus erythematosus associated with etanercept therapy , 2002, The Lancet.

[12]  Lisa A. May,et al.  Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus , 2002, Lupus.

[13]  T. Huizinga,et al.  Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF−308A in systemic lupus erythematosus , 2001, Genes and Immunity.

[14]  R. Allen.  Polymorphism of the human TNF-α promoter — random variation or functional diversity? , 1999 .

[15]  M. Wang,et al.  [Study on the association between tumor necrosis factor alpha gene polymorphism and systemic lupus erythematosus]. , 1999, Zhonghua nei ke za zhi.

[16]  P. Gaffney,et al.  The genetics of human systemic lupus erythematosus. , 1998, Current opinion in immunology.

[17]  Y. Zhang,et al.  [The association of sasceptibility of SLE and the gene polymorphism of TNF]. , 1998, Zhonghua yi xue za zhi.

[18]  George Davey Smith,et al.  Meta-analysis: Principles and procedures , 1997, BMJ.

[19]  M. Petri,et al.  A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. , 1997, Arthritis and rheumatism.

[20]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[21]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[23]  C. Polman,et al.  TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients , 1997, Journal of Neuroimmunology.

[24]  T. Vyse,et al.  Genetic basis of systemic lupus erythematosus. , 1996, Current opinion in immunology.

[25]  J. Smolen,et al.  Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. , 1996, British journal of rheumatology.

[26]  Paul Wordsworth,et al.  Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. , 1996, The Journal of rheumatology.

[27]  R. Scorza,et al.  Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. , 1996, Tissue antigens.

[28]  L. V. D. van de Putte,et al.  A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha , 1994, European journal of immunology.

[29]  R. Goldstein,et al.  Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. , 1993, Arthritis and rheumatism.

[30]  T. Horie,et al.  Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). , 1993, Clinical and experimental rheumatology.

[31]  T. Atsumi.  [Tumor necrosis factor alpha in systemic lupus erythematosus: evaluation by restriction fragment length polymorphism and production by peripheral blood mononuclear cells]. , 1992, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[32]  C. Jacob,et al.  Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. , 1991, Cytokine.

[33]  L. Fugger,et al.  NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. , 1989, Tissue antigens.

[34]  C. Jacob,et al.  Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis , 1988, Nature.

[35]  I. Dunham,et al.  Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[37]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[38]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .

[39]  J. Granados,et al.  Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). , 2001, Genes and immunity.

[40]  M. V. van Krugten,et al.  TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[41]  J. Yen,et al.  The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. , 1997, Immunology letters.

[42]  K. Fong,et al.  Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. , 1996, Annals of the Academy of Medicine, Singapore.

[43]  D. Grennan,et al.  Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. , 1995, Disease markers.

[44]  I. Udalova,et al.  -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. , 1995, Journal of inflammation.

[45]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.